Orthofix Medical Inc. Debt Securities, Available-for-sale, Amortized Cost
Orthofix Medical Inc. (OFIX) had Debt Securities, Available-for-sale, Amortized Cost of $9.00 million as of 2018-12-31, per its 10-K filed 2019-02-25.
Discontinued › Notes › Credit Losses
us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis · last filed 2019-02-25
- 2018-12-31: Debt Securities, Available-for-sale, Amortized Cost $9.00M.
- 2018-09-30: Debt Securities, Available-for-sale, Amortized Cost $9.00M.
- 2018-06-30: Debt Securities, Available-for-sale, Amortized Cost $9.00M.
- 2018-03-31: Debt Securities, Available-for-sale, Amortized Cost $9.00M.
| Period end | Debt Securities, Available-for-sale, Amortized Cost |
|---|---|
| 2018-12-31 | $9.00M 10-K · filed 2019-02-25 |
| 2018-09-30 | $9.00M 10-Q · filed 2018-10-29 |
| 2018-06-30 | $9.00M 10-Q · filed 2018-08-06 |
| 2018-03-31 | $9.00M 10-Q · filed 2018-04-30 |
| 2017-12-31 | $9.00M 10-K · filed 2018-02-26 |
| 2017-09-30 | $18.40M 10-Q · filed 2017-10-30 |
| 2017-06-30 | $18.00M 10-Q · filed 2017-08-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |